People who use cannabis are four times as likely to develop type 2 diabetes as people who do not use cannabis, according to a new study presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) 2025, held in Vienna, Austria, between 15-19 September
Patil HR, Al Badarin FJ, Al Shami HA, et al
Summary: GLP-1 receptor agonist injections must be refrigerated at 28C before first use to preserve their biological activity and therapeutic effectiveness
GLP-1 RAs, however, demonstrate superior efficacy in histological resolution of NASH, with a reported relative risk of 2.48 (95% CI: 1.863.30) compared to placebo
Drugs given concomitantly with narrow therapeutic windows should ensure monitoring is undertaken, especially at initiation of GLP-1 agonists when the effect is most pronounced